HPDC Launches ‘World’s First All-in-One Supply Chain Management Solution for Advanced & Personalized Therapies’
Hypertrust Patient Data Care (HPDC) has launched its extended Hypertrust X-Chain supply chain management solution for Advanced & Personalized Therapies (APT). The company states that it is the first solution that allows biotech and pharmaceutical companies to design, set up, plan, orchestrate, operate and scale APT supply chains with one single system.
The new applications added to Hypertrust X-Chain are:
- An End-to-End Patient Planning & Drug Product Operations Scheduling (PP&DPOS) for APTmodule, enabling real-time calculations of slot assignments and resulting treatment dates in make-to-order environments, and
- A Manufacturing Execution System (MES) for APTincluding hands-free Standard Operating Procedures (SOP) visualizations by augmented reality (AR) for production operators.
Hypertrust X-Chain can be implemented as an all-in-one supply chain management solution or flexibly with a focus on specific modules to complement existing system landscapes.
HPDC adds that different modules of Hypertrust X-Chain are combinable, configurable, and scalable to manage end-to-end supply chain needs across all therapy life cycle phases, from the clinical phase up to post-commercialization.
Click to enlarge.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
